Evidence map›Paper›PMID 37266755›Full record

Observational studyEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2023

Validity and reliability of the Niigata PPPD Questionnaire in a Western population.

Rodrigo Castillejos-Carrasco-Muñoz, Ana Belén Peinado-Rubia, Miguel Ángel Lérida-Ortega, Alfonso Javier Ibáñez-Vera, María Cruz Tapia-Toca, Rafael Lomas-Vega

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06741358 (Use of the Glialia Supplement in the Treatment of Persistent Perceptual Postural Imbalance), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06741358 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Use of the Glialia Supplement in the Treatment of Persistent Perceptual Postural Imbalance: A Triple-Blind, Randomized, Placebo-Controlled Pilot Clinical Trial

TypeinterventionalSponsorI.R.C.C.S. Fondazione Santa LuciaRan2024 to 2026Enrolled30ConditionsPersistent Postural Perceptual DizzinessArmsGlialia, Placebo, Control
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Italian validation of the Niigata Questionnaire to assess the severity of persistent postural-perceptual dizziness.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rodrigo Castillejos-Carrasco-MuñozIntegral Balance Unit, Otorhinolaryngological Institute of Madrid, Madrid, Spain.
Ana Belén Peinado-RubiaDepartment of Health Sciences, University of Jaen, Campus Las Lagunillas, S/N, Building B3, Office 212, 23071, Jaen, Spain.
Miguel Ángel Lérida-OrtegaDepartment of Health Sciences, University of Jaen, Campus Las Lagunillas, S/N, Building B3, Office 212, 23071, Jaen, Spain.
Alfonso Javier Ibáñez-VeraDepartment of Health Sciences, University of Jaen, Campus Las Lagunillas, S/N, Building B3, Office 212, 23071, Jaen, Spain. ajibanez@ujaen.es.ORCID http://orcid.org/0000-0001-9103-9696
María Cruz Tapia-TocaIntegral Balance Unit, Otorhinolaryngological Institute of Madrid, Madrid, Spain.
Rafael Lomas-VegaDepartment of Health Sciences, University of Jaen, Campus Las Lagunillas, S/N, Building B3, Office 212, 23071, Jaen, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyze the psychometric properties of the Niigata Questionnaire (NPQ) for use in a European population with persistent postural-perceptual dizziness (PPPD).

methodsObservational study included 140 patients with different vestibular conditions. Construct validity, internal consistency and concurrent validity were analyzed. Intra-class correlation coefficient (ICC), standard error of measurement (SEM) and minimal detectable change (MDC) were calculated. Receiver operating characteristic (ROC) curve was used to test diagnostic values.

resultsOf the 140 patients, 47 had a diagnosis of PPPD. Factorial analysis showed a single-factor structure and concurrent validity analysis showed strong correlations with other instruments. Cronbach alpha coefficients of 0.938 for the total score, 0.869 for the standing and gait subscale, 0.803 for the subscale of movements and 0.852 for the visual stimulation subscale were obtained. The reproducibility was substantial except for the standing subscale, which could be considered moderate. For the standing, movement and visual stimulation subscales and for the total score, the SEM was 3.27, 2.41, 2.50 and 6.63, respectively, and the MDC was 6.40, 4.72, 4.91 and 12.99, respectively. The NPQ total score showed an area under the curve (AUC) of 0.661, a sensitivity of 72.34 and a specificity of 55.91 for discriminating between PPPD and other vestibular disorders.

conclusionsThe NPQ is feasible for use in a Western population and presents a uni-factorial structure, high internal consistency and strong correlation with other instruments. The reliability can be considered substantial. The NPQ has low accuracy in discriminating between subjects with or without PPPD.

Indexed as

DizzinessVestibular DiseasesHumansPsychometricsReproducibility of ResultsSurveys and QuestionnairesDizzinessReliabilityUnsteadinessValidation studiesVertigo

Identifiers

PMID37266755
PMCPMC10620260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.